Kentucky SB56 establishes utilization controls for nonopioid analgesics in the Medicaid program.
Kentucky SB56 mandates that the Department for Medicaid Services, managed care organizations, and the state pharmacy benefit manager cannot deny federal authorization or approval to implement the Act's provisions. It requires these entities to request necessary federal authorizations to prevent the loss of federal funds or comply with federal law. The Act also allows for more restrictive utilization controls for nonopioid drugs if a state plan amendment, waiver, or other federal authorization is necessary.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.